Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00602199 | ABT-510 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 42 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00897624 | Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma | completed | — | 15 | Institut CurieOTHER | 0 | May 13, 2011 | clinicaltrials |
| NCT00003091 |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma |
| completed |
| Phase 2 |
| 40 |
| Hoag Memorial Hospital PresbyterianOTHER |
| 1 |
| May 12, 2011 |
| clinicaltrials |
| NCT00033228 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 19 | Mannkind CorporationINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00261404 | TNFerade™ Biologic Plus Radiation for Metastatic Melanoma | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00615095 | Differential Risks for Melanoma: p16 and DNA Repair | completed | — | 323 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00700167 | Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00680589 | Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | terminated | Phase 1 / Phase 2 | 11 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT01168050 | Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.(NILOMEL) | unknown | Phase 2 | 25 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT00050102 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT01281722 | Role of SLURP-1 in Melanoma and Melanoma Stem Cells | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00881049 | Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma | completed | Phase 2 | 1 | Peking UniversityOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00746746 | A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma | unknown | Phase 2 | 30 | Ochsner Health SystemOTHER | 1 | Jan 13, 2011 | clinicaltrials |
| NCT00623402 | Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma(SoraPeg) | completed | Phase 2 | 55 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 12, 2011 | clinicaltrials |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | completed | Phase 3 | 855 | Karolinska InstitutetOTHER | 1 | Dec 14, 2010 | clinicaltrials |
| NCT00651703 | Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients | completed | Phase 2 | 21 | Cytos Biotechnology AGINDUSTRY | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00203008 | A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma | completed | — | 2,106 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Oct 18, 2010 | clinicaltrials |
| NCT00221702 | PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)(EADO) | completed | Phase 3 | 898 | University Hospital, BordeauxOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00811759 | Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 58 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00045357 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00327600 | Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma | completed | Phase 1 / Phase 2 | 68 | AmpliMed CorporationINDUSTRY | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00609011 | Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma | completed | Phase 1 / Phase 2 | 22 | Myrexis Inc.INDUSTRY | 1 | Aug 23, 2010 | clinicaltrials |
| NCT01183936 | Trial of Surgical Excision Margins in Thick Primary Melanoma | completed | N/A | 936 | Karolinska InstitutetOTHER | 0 | Aug 18, 2010 | clinicaltrials |
| NCT00966173 | International Melanoma Algorithm Training Study - IMATS | completed | N/A | 1,800 | SciBase ABOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT01005537 | Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma | no longer available | — | — | Fred Hutchinson Cancer CenterOTHER | 0 | Aug 6, 2010 | clinicaltrials |
| NCT00735332 | Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma | terminated | Phase 2 | 49 | Thallion PharmaceuticalsINDUSTRY | 2 | Aug 5, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00688090 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. | completed | Phase 1 | 19 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00963261 | Quality of Life and Psychological Well-being in Patients With Malignant Melanoma | unknown | N/A | 600 | University Hospital FreiburgOTHER | 1 | Jun 25, 2010 | clinicaltrials |
| NCT00153569 | Multiepitope Peptide Vaccination in Melanoma | unknown | Phase 2 | 25 | Charite University, Berlin, GermanyOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00002786 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00045149 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | May 7, 2010 | clinicaltrials |
| NCT00197912 | Dendritic Cell Based Therapy of Malignant Melanoma | completed | Phase 1 / Phase 2 | 25 | Herlev HospitalOTHER | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00729950 | Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma | completed | Phase 1 | 92 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00928031 | Long-term Data Collection for Subjects in MDX-010 Studies(MDX010-28) | completed | — | 160 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00765193 | The Impact of Total Body Skin Examination on Skin Cancer Detection(TBSE) | completed | N/A | 14,381 | Medical University of GrazOTHER | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00034554 | Study of gp75 Vaccine in Patients With Stage III and IV Melanoma | completed | Phase 1 | 31 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00289640 | Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma | completed | Phase 2 | 210 | Bristol-Myers SquibbINDUSTRY | 10 | Mar 2, 2010 | clinicaltrials |
| NCT00991250 | SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma | unknown | Phase 2 | 140 | SentoClone ABINDUSTRY | 1 | Feb 5, 2010 | clinicaltrials |
| NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | unknown | Phase 1 | 12 | Advanced Life Sciences, Inc.INDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00794235 | Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine | completed | Phase 2 | 12 | University of ZurichOTHER | 1 | Jan 8, 2010 | clinicaltrials |
| NCT00584493 | Treatment Use Study for Advanced Melanoma. | no longer available | — | — | PfizerINDUSTRY | 0 | Dec 14, 2009 | clinicaltrials |
| NCT00667901 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | terminated | Phase 1 | 15 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Dec 11, 2009 | clinicaltrials |
| NCT00813449 | Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma(melanoma) | unknown | Phase 2 | 140 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT00116597 | Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma | completed | Phase 1 / Phase 2 | 15 | University Hospital, Basel, SwitzerlandOTHER | 1 | Dec 2, 2009 | clinicaltrials |
Data updated 23 days agoSource updated May 16, 2011source: clinicaltrials